June 22nd 2022, 1:15pm
Dr Thomas Hutson shares his experience with tivozanib in his practice and ways to counsel patients regarding treatment options in the third-line setting.
June 22nd 2022, 1:00pm
Dr Thomas Hutson reviews the adverse event profile of tivozanib and provides advice to community oncologists on how to best manage these toxicities.
June 17th 2022, 1:00pm
Watch Dr. Jeremie Calais, Dr. Tian Zhang, Dr. Landon C. Brown and Jim Rosenfield answer questions about novel agents and strategies during the CURE Educated Patient Prostate Cancer Summit.
June 16th 2022, 1:00pm
Watch Dr. Landon C. Brown, from Atrium Health Levine Cancer Institute, discuss approaches to hormone therapy, during the CURE Educated Patient Prostate Cancer Summit.
June 15th 2022, 7:15pm
Dr Thomas Hutson reviews the TIVO-3 trial, including the most recent data that was presented at ASCO GU.
June 15th 2022, 7:00pm
An overview of the treatment options available for patients with renal cell carcinoma (RCC).
June 15th 2022, 1:00pm
Watch Dr. Tian Zhang, from UT Southwestern Medical Center, discuss novel agents, during the CURE Educated Patient Prostate Cancer Summit.
June 14th 2022, 1:00pm
Watch Dr. Jeremie Calais, from UCLA, discuss novel imaging strategies, during the CURE Educated Patient Prostate Cancer Summit.
June 13th 2022, 1:00pm
Watch Dr. Veda N. Giri, Dr. Umang Swami and Sue Friedman answer questions about genetics and genomics during the CURE Educated Patient Prostate Cancer Summit.
June 12th 2022, 2:00pm
Watch Dr. Umang Swami, from Huntsman Cancer Institute, discuss genomic changes and PARP inhibitors, during the CURE Educated Patient Prostate Cancer Summit.
Tribute to My Husband: A Partner Who Shows Up
Understanding That Not All Lung Cancer Cases Are Linked to Smoking
FDA Fast Tracks FOG-001 After Early Tumor Shrinkage in Desmoid Tumors
Breaking Down Advancements in Prostate Cancer Care